Science & Technology
Development of a novel broad spectrum antifungal therapeutic targeting Glycosylphosphatidylinositol (GPI) biosynthesis and cell wall biogenesis
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R42AI179344-01
Award Ceiling
$595K
Award Floor
$595K
Close Date
Jul 31, 2025
Total Funding
$595K
Expected Awards
1
Posted Date
Aug 15, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-1R42AI179344-01
Description
STTR Phase Phase I award: "Development of a novel broad spectrum antifungal therapeutic targeting Glycosylphosphatidylinositol (GPI) biosynthesis and cell wall biogenesis" awarded to Prokaryotics, Inc. in Union, New Jersey. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $594,918. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.